Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4811 (117th)

Medicare Negotiation and Competitive Licensing Act of 2021

referredUnited States· United States Congress· EN

Introduced

29 July 2021

Last action

8 September 2021 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Doggett, Lloyd [D-TX-37], Rep. Beyer, Donald S. [D-VA-8], Rep. Blumenauer, Earl [D-OR-3], Rep. Bowman, Jamaal [D-NY-16], Rep. Bush, Cori [D-MO-1], Rep. Cartwright, Matt [D-PA-17], Rep. Castro, Joaquin [D-TX-20], Rep. Cicilline, David N. [D-RI-1], Rep. Cleaver, Emanuel [D-MO-5], Rep. Cohen, Steve [D-TN-9], Rep. DeFazio, Peter A. [D-OR-4], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Dingell, Debbie [D-MI-6], Rep. Escobar, Veronica [D-TX-16], Rep. Espaillat, Adriano [D-NY-13], Rep. Garamendi, John [D-CA-8], Rep. García, Jesús G. "Chuy" [D-IL-4], Rep. Green, Al [D-TX-9], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Jackson Lee, Sheila [D-TX-18], Rep. Jayapal, Pramila [D-WA-7], Kaiali'i Kahele, Rep. Kaptur, Marcy [D-OH-9], Rep. Khanna, Ro [D-CA-17], Sen. Kim, Andy [D-NJ], Rep. Krishnamoorthi, Raja [D-IL-8], Rep. Langevin, James R. [D-RI-2], Rep. Lee, Barbara [D-CA-12], Rep. Levin, Andy [D-MI-9], Rep. Lowenthal, Alan S. [D-CA-47], Rep. McNerney, Jerry [D-CA-9], Rep. Mfume, Kweisi [D-MD-7], Rep. Nadler, Jerrold [D-NY-12], Rep. Neguse, Joe [D-CO-2], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Ocasio-Cortez, Alexandria [D-NY-14], Rep. Omar, Ilhan [D-MN-5], Rep. Perlmutter, Ed [D-CO-7], Rep. Pingree, Chellie [D-ME-1], Rep. Pocan, Mark [D-WI-2], Rep. Porter, Katie [D-CA-47], Rep. Pressley, Ayanna [D-MA-7], Rep. Raskin, Jamie [D-MD-8], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Sherman, Brad [D-CA-32], Rep. Takano, Mark [D-CA-39], Rep. Thompson, Bennie G. [D-MS-2], Rep. Titus, Dina [D-NV-1]

Subjects

Healthcare, Taxation

Source updated

6 June 2025

Healthcare · Taxation

Official sourceDownload fileView documentsShare

Summary

Medicare Negotiation and Competitive Licensing Act of 2021 This bill establishes several requirements relating to the prices of prescription drugs. Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under Medicare. (Current law prohibits the CMS from doing so.) If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under health insurance programs, notwithstanding existing government-granted exclusivities. The negotiated prices also apply to other federal health care programs, private health insurance, and the uninsured; pharmacies that charge more than the negotiated price for uninsured individuals are subject to civil penalties. Manufacturers must also comply with specified reporting requirements relating to prices and licensing, subject to civil penalties. The bill also institutes an excise tax on drugs for which the price spikes beyond a certain limit, subject to specified exemptions, as well as on drugs for which the price exceeds the negotiated price.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 29 July 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  2. 29 July 2021

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Oversight and Reform, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 29 July 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 29 July 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 30 July 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  6. 8 September 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 29 July 2021

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 29 July 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 29 July 2021

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 85 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.